Ellevest Inc’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Ellevest Inc’s Portfolio CNST Stock Details CNST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-3	Closed	–	–	1425
2020 Q3	$0	Buy	+3	New	+$73	﹤0.01%	1383

Other funds holding CNST

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Ponoi Management San Francisco, California $73.2M AUM 23.44% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Ellevest Inc's CNST Position: Q4 2020 in Review

Ellevest Inc sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q4 2020, closing a stake of 3 shares.

Ellevest Inc first reported a position in CNST in Q3 2020 and held it in 1 quarter. The position peaked at $0 in Q3 2020. 134 funds tracked by Wall St. Rank hold CNST as of Q4 2020.

Ellevest Inc reported no remaining Constellation Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
Ellevest Inc sold 3 Constellation Pharmaceuticals, Inc. shares in Q4 2020.
Ellevest Inc first reported a position in Constellation Pharmaceuticals, Inc. in Q3 2020 and held it in 1 quarter.
Ellevest Inc's Constellation Pharmaceuticals, Inc. position peaked at $0 in Q3 2020.
134 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q4 2020.

Based on Ellevest Inc's 13F filing for Q4 2020, filed 4 Feb 2021.